retatrutide clinical trial sign up ESC 2024: improves lipid and cardiovascular risk profile in Phase II Retatrutide FDA Approval Status: July

Update on Retatrutide Results from Phase 3 trials have put a new drug called Retatrutide (sometimes called Reta) back in the news again

With their #SleevelessSummer campaign, Sofwave is putting the spotlight on one of the most stubborn (and often most self-conscious) areas of the body: the upper arms

CagriSema is a combination of cagrilintide (an amylin analog) and semaglutide

What if I accidentally swallow the drops immediately

Always consult your healthcare provider before making any medical decisions

From prescription to delivery After the physician approves your prescription, it goes to one of several partner compounding pharmacies